BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15880483)

  • 21. A pilot study of tacrolimus and mycophenolate mofetil graft-versus-host disease prophylaxis in childhood and adolescent allogeneic stem cell transplant recipients.
    Osunkwo I; Bessmertny O; Harrison L; Cheung YK; Van de Ven C; del Toro G; Garvin J; George D; Bradley MB; Wolownik K; Wischhover C; Levy J; Skerrett D; Cairo MS
    Biol Blood Marrow Transplant; 2004 Apr; 10(4):246-58. PubMed ID: 15077223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Limb allotransplantation in rats: combined immunosuppression by FK-506 and 15-deoxyspergualin.
    Muramatsu K; Doi K; Kawai S
    J Hand Surg Am; 1999 May; 24(3):586-93. PubMed ID: 10357540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of FK 506, mycophenolate mofetil, and aminoguanidine effects on delay of corneal allograft rejection in an experimental model of low-risk and high-risk keratoplasty.
    Svozílková P; Bysterská P; Masek K; Valenta Z; Zvárová J; Farghali H
    Immunopharmacol Immunotoxicol; 2006; 28(2):335-40. PubMed ID: 16873100
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of nutritional immunomodulation on cardiac allograft survival in rats receiving mycophenolate mofetil, cyclosporine A, and donor-specific transfusion.
    Gibson SW; Valente JF; Alexander JW; Custer DA; Babcock GF; Ogle CK
    J Heart Lung Transplant; 1999 Mar; 18(3):185-9. PubMed ID: 10328142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of tacrolimus (FK506) and mycophenolate mofetil (MMF) on regulatory T cells and co-inhibitory receptors in the peripheral blood of human liver allograft patients.
    Zeng Q; Yuan XY; Li W; Liu BW; Zhao X; Ren GJ; Wang Y; Dou J; Wang GY
    Immunopharmacol Immunotoxicol; 2019 Jun; 41(3):380-385. PubMed ID: 30633591
    [No Abstract]   [Full Text] [Related]  

  • 26. The effect of full dose composite tissue allotransplantation immunosuppression on allograft motor nerve regeneration in a rat sciatic nerve model.
    Kim JP; Hundepool CA; Friedrich PF; Moran SL; Bishop AT; Shin AY
    Microsurgery; 2018 Jan; 38(1):66-75. PubMed ID: 28792625
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential immunological advantage of intravenous mycophenolate mofetil with tacrolimus and steroids in primary deceased donor liver transplantation and live donor liver transplantation without antibody induction.
    Jain A; Sharma R; Ryan C; Tsoulfas G; Orloff M; Abt P; Kashyap R; Batzold P; Sauberman L; Safadjou S; Graham M; Bozorgzadeh A
    Liver Transpl; 2008 Feb; 14(2):202-9. PubMed ID: 18236395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intra-graft injection of tacrolimus promotes survival of vascularized composite allotransplantation.
    Olariu R; Denoyelle J; Leclère FM; Dzhonova DV; Gajanayake T; Banz Y; Hayoz M; Constantinescu M; Rieben R; Vögelin E; Taddeo A
    J Surg Res; 2017 Oct; 218():49-57. PubMed ID: 28985877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rescue immunosuppressive therapies in living-related renal allotransplant: a long-term prospective randomized evaluation.
    Bakr MA; Gheith OA; Ismael AM; Baz ME; Shehab El-Dein AB; Ghoneim MA
    Exp Clin Transplant; 2008 Mar; 6(1):48-53. PubMed ID: 18405245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Foetal rat pancreatic transplantation: posttransplantation development of foetal pancreatic iso- and allografts and suppression of rejection with mycophenolate mofetil (MMF) and cyclosporine based immunesuppression.
    du Toit D; Muller C; Page B; Louw J
    Microsc Res Tech; 1998 Nov; 43(4):347-55. PubMed ID: 9849976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dosing of MMF in combination with tacrolimus for steroid-resistant vascular rejection in pediatric renal allografts.
    Filler G; Lampe D; Mai I; Strehlau J; Ehrich JH
    Transpl Int; 1998; 11 Suppl 1():S82-5. PubMed ID: 9664950
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of mycophenolate mofetil, cyclosporin A, and both in combination in a murine corneal graft rejection model.
    Reis A; Reinhard T; Sundmacher R; Braunstein C; Godehardt E
    Br J Ophthalmol; 1998 Jun; 82(6):700-3. PubMed ID: 9797676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Donor leukocytes combined with delayed immunosupressive drug therapy prolong limb allograft survival.
    Matsumoto T; Kanatani T; Lanzetta M; Fujioka H; Kurosaka M; McCaughan GW; Bishop GA
    Transplant Proc; 2005 Dec; 37(10):4630-3. PubMed ID: 16387186
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of the severity of acute rejection in the early phase after rat lung transplantation on the effectiveness of mycophenolate mofetil to treat chronic allograft rejection.
    von Suesskind-Schwendi M; Hirt SW; Diez C; Ruemmele P; Puehler T; Schmid C; Lehle K
    Eur J Cardiothorac Surg; 2012 Jul; 42(1):142-8. PubMed ID: 22398468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tacrolimus combined with mycophenolate mofetil can effectively reverse C4d-positive steroid-resistant acute rejection in Chinese renal allograft recipients.
    Sun Q; Liu ZH; Yin G; Chen H; Chen J; Ji S; Li LS
    Nephrol Dial Transplant; 2006 Feb; 21(2):510-7. PubMed ID: 16421166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of RS61443 in combination with leflunomide or FK506 on rat heart allograft survival.
    Antoniou E; DeRoover A; Nishimura Y; Howie AJ; McMaster P; D'Silva M
    Transpl Int; 1996; 9 Suppl 1():S331-3. PubMed ID: 8959858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination effect of mycophenolate mofetil with mizoribine on cell proliferation assays and in a mouse heart transplantation model.
    Shimmura H; Tanabe K; Habiro K; Abe R; Toma H
    Transplantation; 2006 Jul; 82(2):175-9. PubMed ID: 16858279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myeloablative irradiation, granulocyte-colony stimulating factor, and FK506 can induce macrochimerism and prolong the survival of experimental extremity allografts.
    Muramatsu K; Kato H; Yoshida Y; Moriya A; Okimoto T; Taguchi T
    J Surg Res; 2011 Dec; 171(2):807-13. PubMed ID: 20538288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-IL2 induction in liver transplantation with 93% rejection-free patient and graft survival at 18 months.
    Ramirez CB; Doria C; di Francesco F; Iaria M; Kang Y; Marino IR
    J Surg Res; 2007 Apr; 138(2):198-204. PubMed ID: 17292404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.